CIPRIANI, MARTA
 Distribuzione geografica
Continente #
EU - Europa 320
AS - Asia 86
NA - Nord America 49
AF - Africa 4
OC - Oceania 1
Totale 460
Nazione #
IT - Italia 273
SG - Singapore 46
US - Stati Uniti d'America 44
CN - Cina 16
FI - Finlandia 11
ID - Indonesia 8
NL - Olanda 6
BG - Bulgaria 4
CA - Canada 4
DE - Germania 4
DK - Danimarca 4
ES - Italia 4
HK - Hong Kong 4
PH - Filippine 4
FR - Francia 3
CH - Svizzera 2
DZ - Algeria 2
ET - Etiopia 2
GB - Regno Unito 2
NO - Norvegia 2
SA - Arabia Saudita 2
TR - Turchia 2
BE - Belgio 1
BM - Bermuda 1
HU - Ungheria 1
IE - Irlanda 1
IN - India 1
IQ - Iraq 1
JO - Giordania 1
JP - Giappone 1
NZ - Nuova Zelanda 1
SE - Svezia 1
UA - Ucraina 1
Totale 460
Città #
Rome 84
Singapore 35
Milan 26
Florence 15
Santa Clara 15
Jakarta 8
Lappeenranta 8
Palermo 7
New York 6
Formia 5
Naples 5
Udine 5
Boardman 4
Bologna 4
Hong Kong 4
Lettele 4
Randers 4
Sofia 4
Turin 4
Campodarsego 3
Casier 3
Catania 3
Forlì 3
Helsinki 3
Lanzo d'Intelvi 3
Toronto 3
Venafro 3
Vicenza 3
Addis Ababa 2
Al Qatif 2
Alessandria 2
Bari 2
Frascati 2
Genazzano 2
Genoa 2
Göttingen 2
Istanbul 2
Lausanne 2
Lido di Ostia 2
Livorno 2
Madrid 2
Monte Porzio Catone 2
Montesilvano Marina 2
Oran 2
Oslo 2
Paris 2
Robbiate 2
San Giuseppe Vesuviano 2
Teramo 2
Tribiano 2
Vado Ligure 2
Valencia 2
Albignasego 1
Amman 1
Aprilia 1
Ashburn 1
Auckland 1
Bergamo 1
Boston 1
Budapest 1
Cagliari 1
Cesena 1
Chicago 1
Cleveland 1
Columbia 1
Davao City 1
Dublin 1
Edmonton 1
Erbil 1
Ferrara di Monte Baldo 1
Frankfurt am Main 1
Gualtieri 1
Hamilton 1
Jena 1
Kochi 1
London 1
Lucera 1
Muizen 1
Nepi 1
Oderzo 1
Padova 1
Prescot 1
San Cipriano d'Aversa 1
Santa Maria 1
Terni 1
Tokyo 1
Treviso 1
Totale 357
Nome #
Addition of venetoclax to FLAI induction chemotherapy (VFLAI) improves survival in patients with intermediate and high-risk AML vs FLAI and 3+7: A GIMEMA Italian cooperative analysis 96
Pseudo-observations in survival analysis 61
Health-Related Quality of Life and Financial Burden of Ethiopian Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors 51
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting 48
The Addition of Venetoclax to Induction Chemotherapy in No Low-Risk AML Patients: A Propensity Score-Matched Analysis of the Gimema AML1718 and AML1310 Trials 48
P499: APPLICABILITY OF 2022 CLASSIFICATIONS OF ACUTE MYELOID LEUKEMIA IN THE REAL-WORLD SETTING 44
P523: The comparison of VFLAI, FLAI and 3 + 7 regimens by multilevel propensity score weighting highlights the benefit of the addition of venetoclax in no low risk aml treated in Gimema trials real world 34
P495: UNLOCKING THE POTENTIAL OF SYNTHETIC PATIENTS FOR ACCELERATING CLINICAL TRIALS: RESULTS OF THE FIRST GIMEMA EXPERIENCE 27
The Promotoer, a brain-computer interface-assisted intervention to promote upper limb functional motor recovery after stroke: a statistical analysis plan for a randomized controlled trial 25
S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDY 16
Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients 16
Unraveling the impact of 2022 classifications on secondary acute myeloid leukemia: assessing the true qualification power of diagnostic qualifiers 12
null 10
A Propensity Score Weighting Analysis Emphasizes the Progress of the Gimema Approach in Adult Ph-Positive Acute Lymphoblastic Leukemia in the TKI Era 10
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS). The statistical analysis plan of TUDCA-ALS trial 10
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial 5
Current Knowledge on Breast Implant-Associated Anaplastic Large Cell Lymphoma: Evidence from Italian Ministry of Health Registry Data 3
Totale 516
Categoria #
all - tutte 2.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202335 0 0 0 0 0 0 0 8 8 3 6 10
2023/2024308 12 9 30 33 44 42 27 25 9 28 11 38
2024/2025173 25 25 31 43 49 0 0 0 0 0 0 0
Totale 516